Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 – – Completed enrollment in Explore-CKD Phase 2 trial and anticipate ...
Triple T offers a faster, safer alternative to surgery, by selectively destroying the small adrenal nodule without removing the adrenal gland.
Doctors at Queen Mary University of London, Barts Health NHS Trust, and University College London have led the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results